GENE ONLINE|News &
Opinion
Blog

Partner
Defeating Head and Neck Cancer, From Combination Therapy to Photoimmunotherapy
2022-09-15Partner
Caliway Biopharmaceutical Announces Achievements in Revolutionary Fat Reduction Therapy
2022-08-02Partner
Reinvigorating the Asian Biomedical Ecosystem With BIO Asia-Taiwan 2022
2022-07-26Partner
Taiwan’s Biotech Industry Shines at the 2022 BIO International Convention
2022-06-24Partner
BIO Asia-Taiwan 2022: Connecting the Asian Value Chain
2022-06-14Partner
Over 50 Taiwan Organizations to Present at 2022 BIO International Convention
2022-06-08Partner
CYTENA BPS and Leadgene Bio to Level Up Taiwan’s Protein Drugs Production
2022-06-05Partner
APCM 2022: Precision Medicine Is Opening Up a New Prospect of Cancer Therapy
2022-05-04Partner
How the IHMED Reproductive Center Improves Infertility Outcomes by Targeting Immune Response
2022-04-19Partner
AMS BioteQ Touts Antimicrobial Dressings for Chronic Wound Infections
2022-04-13Partner
Fifth Wave of COVID-19 Devastates Hong Kong – How Next-Generation Sequencing Can Help with Latest Outbreak
2022-03-08Partner
The 2022 UK-Taiwan Digital Health Programme, Linking the Medical and Technology Strength of the UK and Taiwan!
2022-03-04Partner
The Golden Age of Genomics Sequencing
2022-02-20Partner
Digital Health Programme to Connect British and Taiwanese Leaders
2022-01-17Partner
CYTENA Bioprocess Solutions Closes $5M Funding to Develop Automatic High-throughput Screening Platform for Pharmaceuticals
2021-10-05Partner
1 2 3 5
LATEST
AstraZeneca Welcomes Neurofibromatosis And Asthma Treatment Approvals in Japan
2022-09-28
Biogen Concludes $900 Million Settlement Before Posting Positive Data From Alzheimer’s Trial
2022-09-28
Arsenal Biosciences Announced Another $70 million Collaboration, This Time With Genentech
2022-09-27
Sciwind Biosciences And SynerK Join Forces To Develop siRNA Therapeutics
2022-09-27
Acticor Enrolls First Patient in Phase 2/3 Stroke Treatment Study
2022-09-27
Daiichi Sankyo Wins Approval For Cancer Treatment in Japan
2022-09-26
Seagen Strikes Potential $650 million Deal with LAVA Therapeutics for Cancer Treatment
2022-09-26
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!